Novabay Pharmaceuticals Inc.
13F holders, Q3 2025 (September 30)14holders +1
6new positions
5sold out
$1.28avg. 13F price*
At the end of Q3 2025, 14 institutions reported holding Novabay Pharmaceuticals Inc. in their 13F filings, up 1 from Q2 2025. 6 opened new positions and 5 sold out. The largest holders were Vanguard Group Inc. ($108K), Geode Capital Management, LLC ($66K) and State Street Corp. ($38K).
- Company
- Novabay Pharmaceuticals Inc.
- CUSIP
- 66987P409
- Latest filing quarter
- Q4 2025
History
Number of 13F holders
Total Exit/New Position Q2 2025 → Q3 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 6 | $222K |
| Exits | 5 | $104K |
All 13F filers, Q2 2025 → Q3 2025: 191,832 shares bought and 183,695 shares sold, net +8,137 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 14 holders
| Vanguard Group Inc. | 0.00% | New | 84,488 | $108K |
| Geode Capital Management, LLC | 0.00% | Add +52.9% | 51,721 | $66K |
| State Street Corp. | 0.00% | New | 29,303 | $38K |
| Apollon Wealth Management, LLC | 0.00% | New | 27,561 | $35K |
| Ground Swell Capital, LLC | 0.05% | New | 19,158 | $25K |
| Virtu Financial LLC | 0.00% | New | 11,091 | $14K |
| Citigroup Inc. | 0.00% | New | 2,333 | $3K |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -82.6% | 948 | $1K |
| Bank of America Corp. | 0.00% | Reduce -12.7% | 48 | $61 |
| Morgan Stanley | 0.00% | No change | 3 | $4 |
| Nvwm, LLC | 0.00% | No change | 3 | $4 |
| Addison Advisors LLC | 0.00% | No change | 1 | $2 |
| Northwestern Mutual Wealth Management Co. | 0.00% | No change | 1 | $1 |
| Royal Bank of Canada | 0.00% | No change | 1 | $0 |
"% of holder's portfolio" is NOVABAY PHARMACEUTICALS INC's weight in each manager's 13F, not the share of Novabay Pharmaceuticals Inc. the manager owns.